Latest Breaking News On - Prnewswire cantex pharmaceuticals inc - Page 1 : comparemela.com

CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE

/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other.

New yorkUnited statesMarriott marquisDaniel kontoh boatengJuanf rodriguezStephen marcusCasey mcdonaldStepheng marcusTv therapeutics incCantex pharmaceuticals incPrnewswire cantex pharmaceuticals incChief executive officerNew york marriott marquisCantex pharmaceuticalsHealth care amp hospitalsMedical pharmaceuticals

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

WESTON, Fla. and ANN ARBOR, Mich., Sept. 27, 2023 /PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and.

United statesSalim hayekJuanf rodriguezCasey mcdonaldStepheng marcusDaniel kontoh boatengUniversity of michiganTv therapeutics incFrankel cardiovascular centerUniversity of michigan healthKellogg eye centerPrnewswire cantex pharmaceuticals incCantex pharmaceuticals incUniversity hospitalTiberend strategic advisors incRogel cancer center

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19
yoursourceone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yoursourceone.com Daily Mail and Mail on Sunday newspapers.

United statesSalim hayekCasey mcdonaldDaniel kontoh boatengJuanf rodriguezStepheng marcusKellogg eye centerUniversity hospitalRogel cancer centerUniversity of michiganTv therapeutics incCantex pharmaceuticals incUniversity of michigan healthFrankel cardiovascular centerPrnewswire cantex pharmaceuticals incMichigan medicine

Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer

/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other.

United statesWest virginiaNew yorkCasey mcdonaldNathan baharyJuanf rodriguezDaniel kontoh boatengStepheng marcusTv therapeutics incPrnewswire cantex pharmaceuticals incAmerican society for radiation oncologyCantex pharmaceuticals incOncology at allegheny health network cancer instituteFoundation for accreditation of cellular therapyCancer instituteNational cancer institute

CANTEX PHARMACEUTICALS AND LENOX HILL HOSPITAL ANNOUNCE INITIATION OF A PHASE 2 STUDY OF RAGE INHIBITOR AZELIRAGON AS A FRONT-LINE TREATMENT FOR UNMETHYLATED GLIOBLASTOMA

/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other.

New yorkUnited statesLenox hill hospitalCold spring harbor laboratoryStepheng marcusDaniel kontoh boatengJuanf rodriguezLenox hillCasey mcdonaldTamika wongNorthwell lenox hillJohn boockvarCantex pharmaceuticals incProfessor at cold spring harbor laboratoryPrnewswire cantex pharmaceuticals incLenox hill hospital department of neurological surgery